Despite their importance, the molecular circuits that control the differentiation of naive T cells remain largely unknown. Recent studies that reconstructed regulatory networks in mammalian cells have focused on short-term responses and relied on perturbation-based approaches that cannot be readily applied to primary T cells. Here we combine transcriptional profiling at high temporal resolution, novel computational algorithms, and innovative nanowirebased perturbation tools to systematically derive and experimentally validate a model of the dynamic regulatory network that controls the differentiation of mouse T H 17 cells, a proinflammatory T-cell subset that has been implicated in the pathogenesis of multiple autoimmune diseases. The T H 17 transcriptional network consists of two self-reinforcing, but mutually antagonistic, modules, with 12 novel regulators, the coupled action of which may be essential for maintaining the balance between T H 17 and other CD4 1 T-cell subsets. Our study identifies and validates 39 regulatory factors, embeds them within a comprehensive temporal network and reveals its organizational principles; it also highlights novel drug targets for controlling T H 17 cell differentiation.
by transient induction (for example, cluster C5, Fig. 1b ) of immune response pathways (for example, IL-6 and TGF-b signalling; Supplementary Table 2 ). Some early induced genes display sustained expression (for example, cluster C10, Fig. 1b ); these are enriched for transcription factors, including the key T H 17 factors Stat3, Irf4 and Batf, and the cytokine and cytokine receptors Il21, Lif and Il2ra (Supplementary Table 1 ). The transition to the intermediate phase (t 5 4 h) is marked by induction of the Rorc gene (encoding the master transcription factor ROR-ct; Supplementary Fig. 1d ) and another 12 transcription factors (cluster C20, Fig. 1b ), both known (for example, Ahr) and novel (for example, Trps1) in T H 17 differentiation. During the transition to the late phase (t 5 20 h), mRNAs of T H 17 signature cytokines are induced (for example, Il17a, Il9; cluster C19) whereas mRNAs of cytokines that signal other T-cell lineages are repressed (for example, Ifng and Il4). Regulatory cytokines from the IL-10 family are also induced (Il10, Il24), possibly as a self-limiting mechanism related to the emergence of 'pathogenic' or 'non-pathogenic' T H 17 cells 11 . Around 48 h, the cells induce Il23r (data not shown), which has an important role in the late phase ( Supplementary Fig. 3 and Supplementary Table 1 ).
Inference of dynamic regulatory interactions
We proposed the hypothesis that each of the clusters ( Fig. 1b and Supplementary Table 2 ) encompasses genes that share regulators active in the relevant time points. To predict these regulators, we assembled a general network of regulator-target associations from published genomics profiles [12] [13] [14] [15] [16] [17] [18] [19] (Fig. 2a and Methods). We then connected a regulator to a gene from its set of putative targets only if there was also a significant overlap between the regulator's putative targets and that gene's cluster (Methods). Because different regulators act at different times, the connection between a regulator and its target may be active only within a certain time window. To determine this window, we labelled each edge with a time stamp denoting when both the target gene is regulated (based on its expression profile) and the regulator node is expressed at sufficient levels (based on its mRNA levels and inferred protein levels 20 ; Methods). In this way, we derived a network 'snapshot' for each of the 18 time points ( Fig. 2b-d) . Overall, 10,112 interactions between 71 regulators and 1,283 genes were inferred in at least one network.
Substantial regulatory re-wiring during differentiation The active factors and interactions change from one network to the next. The vast majority of interactions are active only at some time windows ( Fig. 2c ), even for regulators (for example, Batf) that participate in all networks. On the basis of similarity in active interactions, we identified three network classes ( Fig. 2c ) corresponding to the three differentiation phases (Fig. 2d ). We collapsed all networks in each phase into one model, resulting in three consecutive network models ( Fig. 2d, Supplementary Fig. 4 and Supplementary Table 3 ). Among the regulators, 33 are active in all of the networks (for example, known master regulators such as Batf, Irf4 and Stat3), whereas 18 are active primarily in one (for example, Stat1 and Irf1 in the early network; ROR-ct in the late network). Indeed, whereas Rorc mRNA levels are induced at ,4 h, ROR-ct protein levels increase 
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at approximately 20 h and further rise over time, consistent with our model ( Supplementary Fig. 5 ).
Ranking novel regulators for systematic perturbation
In addition to known T H 17 regulators, our network includes dozens of novel factors as predicted regulators ( Fig. 2d ), induced target genes, or both (Supplementary Fig. 4 and Supplementary Table 3 ). It also contains receptor genes as induced targets, both previously known in T H 17 cells (for example, Il1r1, Il17ra) and novel (for example, Fas, Itga3). We ranked candidate regulators for perturbation (Figs 2a and 3a; see Methods), guided by features that reflect a regulatory role ( Fig. 3a , 'Network information') and a role as a target ( Fig. 3a , 'Gene expression information'). We computationally ordered the genes to emphasize certain features (for example, a predicted regulator of key T H 17 genes) over others (for example, differential expression in our time course data). We used a similar scheme to rank receptor proteins ( Supplementary Table 4 and Methods). Supporting their quality, our top-ranked factors are enriched (P , 10 23 ) for manually curated T H 17 regulators ( Supplementary Fig. 6 ), and correlate well (Spearman r . 0.86) with a ranking learned by a supervised method (Methods). We chose 65 genes for perturbation: 52 regulators and 13 receptors ( Supplementary Table 4 ). These included most of the top 44 regulators and top 9 receptors (excluding a few well known T H 17 genes and/or those for which knockout data already existed), as well as additional representative lower ranking factors.
Nanowire-based perturbation of primary T cells
In unstimulated primary mouse T cells, viral-or transfection-based siRNA delivery has been nearly impossible because it either alters differentiation or cell viability 21, 22 . We therefore used a new delivery technology based on silicon nanowires 10, 23 , which we optimized to deliver siRNA effectively (.95%) into naive T cells without activating them (Fig. 3b, c 
ARTICLE RESEARCH
We attempted to perturb 60 genes with nanowire-mediated siRNA delivery and achieved efficient knockdown (,60% transcript remaining at 48 h post-activation) for 34 genes ( Fig. 3c and Supplementary  Fig. 7 ). We obtained knockout mice for seven other genes, two of which (Irf8 and Il17ra) were also in the knockdown set (Supplementary Table 4 ). Altogether, we successfully perturbed 39 of the 65 selected genes-29 regulators and 10 receptors-including 21 genes not previously associated with T H 17 differentiation.
Nanowire-based screen validates 39 network regulators
We measured the effects of perturbations at 48 h post-activation on the expression of 275 signature genes using the Nanostring nCounter system ( Supplementary Tables 5 and 6 ; Il17ra and Il21r knockouts were also measured at 60 h). The signature genes were computationally chosen to cover as many aspects of the differentiation process as possible (Methods): they include most differentially expressed cytokines, transcription factors, and cell-surface molecules, as well as representatives from each cluster ( Fig. 1b ) or enriched function (Supplementary Table 2 ), and predicted targets in each network (Supplementary Table 3 ). For validation, we profiled a signature of 86 genes using the Fluidigm BioMark system, obtaining highly reproducible results ( Supplementary Fig. 8 ).
We scored the statistical significance of a perturbation's effect on a signature gene by comparing to non-targeting siRNAs and to 18 control genes that were not differentially expressed (Supplementary Information and Fig. 4a , all non-grey entries are significant). Supporting the original network model (Fig. 2 ), there is a significant overlap between the genes affected by a regulator's knockdown and its predicted targets (P # 0.01, permutation test; Supplementary Information).
To study the network's dynamics, we measured the effect of 28 of the perturbations at 10 h (shortly after the induction of Rorc; Supplementary Table 5 ) using the Fluidigm BioMark system. We found that 30% of the functional interactions are present with the same activation/repression logic at both 10 h and 48 h, whereas the rest are present only in one time point ( Supplementary Fig. 9 ). This is consistent with the extent of rewiring in our original model ( Fig. 2c ).
Two coupled antagonistic circuits in the T H 17 network
Characterizing each regulator by its effect on T H 17 signature genes (for example, Il17a, Il17f; Fig. 4b , grey nodes, bottom), we found that, at 48 h, the network is organized into two antagonistic modules: a module of 22 Ccr6
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Figure 3 | Knockdown screen in T H 17 differentiation using silicon nanowires. a, Unbiased ranking of perturbation candidates. Shown are the genes ordered from left to right based on their ranking for perturbation (columns, top ranking is left-most). Two top matrices: criteria for ranking by 'Network information' (topmost) and 'Gene expression information'. Purple entry: gene has the feature (intensity proportional to feature strength; top five features are binary). Bar chart indicates ranking score. 'Perturbed' row: dark grey, genes successfully perturbed by knockdown followed by high-quality mRNA quantification; light grey, genes that we attempted to knockdown but could not achieve or maintain sufficient knockdown or did not obtain enough replicates; Black, genes that we perturbed by knockout or for which knockout data were already available. Known row: orange entry: a gene was previously associated with T H 17 function (this information was not used to rank the genes; Supplementary Fig. 6 ). b, Scanning electron micrograph of primary T cells (false-coloured purple) cultured on vertical silicon nanowires. c, Effective knockdown by siRNA delivered on nanowires. Shown is the percentage of mRNA remaining after knockdown (by qPCR, y axis: mean 6 standard error relative to non-targeting siRNA control, n 5 12, black bar on left) at 48 h after activation.
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(70% of the intra-module edges), whereas most (88%) inter-module interactions are negative. This organization, which is statistically significant (empirical P value ,10 23 ; Methods, Supplementary Fig. 10 ), is reminiscent of that observed previously in genetic circuits in yeast 24, 25 . At 10 h, the same regulators do not yield this clear pattern (P . 0.5), suggesting that, at that point, the network is still malleable. The two antagonistic modules may have a key role in maintaining the balance between T H 17 and other T-cell subsets and in self-limiting the pro-inflammatory status of T H 17 cells. Indeed, perturbing T H 17-positive factors also induces signature genes of other T-cell subsets, whereas perturbing T H 17-negative factors suppresses them (for example, Foxp3, Gata3 and Stat4; Fig. 4b , grey nodes, top).
Validation and characterization of novel factors
Next, we focused on the role of 12 of the positive or negative factors (including 11 of the 12 novel factors that have not been associated with T H 17 cells; Fig. 4b , light-grey halos). After knockdown of each factor, we used RNA-seq analysis to test whether its predicted targets
Etv6 Fig. 2a (pink circle) to the set of genes that respond to that factor's knockdown in an RNA-seq experiment (yellow circle). Bar chart (bottom): shown is the 2log 10 (P value) (y axis, hypergeometric test) for the significance of this overlap for four factors (x axis). Similar results were obtained with a non-parametric rank-sum test (Mann-Whitney U-test, Supplementary Information). Red dashed line: P 5 0.01. d, Global knockdown effects are consistent across clusters. Venn diagram: we compare the set of genes that respond to a factor's knockdown in an RNA-seq experiment (yellow circle) to each of the 20 clusters of Fig. 1b (purple circle) . We expect the knockdown of a 'T H 17 positive' regulator to repress genes in induced clusters, and induce genes in repressed clusters (and vice versa for 'T H 17 negative' regulators). Heat map: for each regulator knockdown (rows) and each cluster (columns) shown are the significant overlaps (non-grey entries) by the test above. Red, fold enrichment for upregulation upon knockdown; blue, fold enrichment for downregulation upon knockdown. Orange entries in the top row indicate induced clusters.
ARTICLE RESEARCH (Fig. 2) were affected (Fig. 4c , Venn diagram, top). We found highly significant overlaps (P , 10 25 ) for three of the factors (Egr2, Irf8 and Sp4) that exist in both data sets, and a borderline significant overlap for the fourth (Smarca4), validating the quality of the edges in our network.
Next, we assessed the designation of each of the 12 factors as 'T H 17 positive' or 'T H 17 negative' by comparing the set of genes that respond to that factor's knockdown (in RNA-seq) to each of the 20 clusters (Fig. 1b) . Consistent with the original definitions, knockdown of a T H 17-positive regulator downregulated genes in otherwise induced clusters and upregulated genes in otherwise repressed or uninduced clusters (and vice versa for T H 17-negative regulators; Fig. 4d and Supplementary Fig. 11a, b) . The genes affected by either positive or negative regulators also significantly overlap with those bound by key Supplementary Tables  5 and 7) , while increasing the expression of Foxp3, the master transcription factor of T reg cells. Mina is strongly induced during T H 17 differentiation (cluster C7), is downregulated in Il23r 2/2 T H 17 cells, and is a predicted target of Batf 30 , ROR-ct 30 and Myc in our model (Fig. 5a ). Mina was shown to suppress T H 2 bias by interacting with the transcription factor NFAT and repressing the Il4 promoter 31 . However, in our cells, Mina knockdown did not induce T H 2 genes, indicating an alternative mode of action via positive feedback loops between Mina, Batf and ROR-ct ( Fig. 5a, left) . Consistent with this model, Mina expression is reduced in T H 17 cells from Rorc knockout mice, and the Mina promoter was found to be bound by ROR-ct by ChIP-seq (data not shown). Finally, the genes induced by Mina knockdown significantly overlap with those bound by Foxp3 in T reg cells 26, 27 (P , 10 225 ; Supplementary Table 7 ) and with a cluster previously linked to Foxp3 activity in T reg cells 32 ( Supplementary Fig. 11c and Supplementary Table 7 ).
To analyse the role of Mina further, we measured IL-17a and Foxp3 expression after differentiation of naive T cells from Mina 2/2 mice. Mina 2/2 cells had decreased IL-17a and increased Foxp3 1 T cells compared to wild-type cells, as detected by intracellular staining (Fig. 5a ). Cytokine analysis of the corresponding supernatants confirmed a decrease in IL-17a production and an increase in IFN-c ( Fig. 5a ) and TNF-a ( Supplementary Fig. 12a ). This is consistent with a model where Mina, induced by ROR-ct and Batf, promotes transcription of Rorc, while suppressing induction of Foxp3, thus affecting the reciprocal T reg /T H 17 balance 33 by favouring rapid T H 17 differentiation.
Fas promotes the T H 17 program and suppresses IFN-c
Fas, the TNF receptor superfamily member 6, is another T H 17-positive regulator (Fig. 5b) . Fas is induced early and is a target of Stat3 and Batf in our model. Fas knockdown represses the expression of key T H 17 genes (for example, Il17a, Il17f, Hif1a, Irf4 and Rbpj) and of the induced cluster C14, and promotes the expression of T H 1-related genes, including Ifngr1 and Klrd1 (CD94; by RNA-seq, Figs 4, 5b, Supplementary Table 7 and Supplementary Fig. 11 ). Fas-and Fasligand-deficient mice are resistant to the induction of autoimmune encephalomyelitis (EAE) 34 , but have no defect in IFN-c or T H 1 responses. The mechanism underlying this phenomenon has not been identified.
To explore this, we differentiated T cells from Fas 2/2 mice ( Fig. 5b and Supplementary Fig. 12c ). Consistent with our knockdown analysis, expression of IL-17a was strongly repressed and IFN-c production was strongly increased under both T H 17 and T H 0 polarizing conditions (Fig. 5b) . These results suggest that besides being a death receptor, Fas may have an important role in controlling the T H 1/T H 17 balance, and Fas 2/2 mice may be resistant to EAE due to lack of T H 17 cells.
Pou2af1 promotes the T H 17 program and suppresses IL-2 expression
Knockdown of Pou2af1 (also called OBF1) strongly decreases the expression of T H 17 signature genes ( Fig. 5c ) and of intermediateand late-induced genes (clusters C19 and C20, P , 10 27 ; Supplementary Tables 5 and 7) , while increasing the expression of regulators of other CD4 1 subsets (for example, Foxp3, Stat4, Gata3) and of genes in 
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non-induced clusters (clusters C2 and C16, P , 10 29 ; Supplementary  Table 5 and 7). The role of Pou2af1 in T-cell differentiation has not been explored 35 .
To investigate its effects, we differentiated T cells from Pou2af1 2/2 mice ( Fig. 5c and Supplementary Fig. 12b ). Compared to wild-type cells, IL-17a production was strongly repressed. Interestingly, IL-2 production was strongly increased in Pou2af1 2/2 T cells under non-polarizing (T H 0) conditions. Thus, Pou2af1 may promote T H 17 differentiation by blocking production of IL-2, a known endogenous repressor of T H 17 cells 36 . Pou2af1 acts as a transcriptional coactivator of the transcription factors Oct1 or Oct2 (ref. 35 ). IL-17a production was also strongly repressed in Oct1-deficient cells ( Supplementary Fig. 12d ), suggesting that Pou2af1 may exert some of its effects through this co-factor.
Tsc22d3 may limit T H 17 generation and inflammation
Knockdown of the TSC22 domain family protein 3 (Tsc22d3) increases the expression of T H 17 cytokines (Il17a, Il21) and transcription factors (Rorc, Rbpj, Batf), and reduces Foxp3 expression. Previous studies in macrophages have shown that Tsc22d3 expression is stimulated by glucocorticoids and IL-10, and it has a key role in their antiinflammatory and immunosuppressive effects 37 . Tsc22d3 knockdown in T H 17 cells increased the expression of Il10 and other key genes that enhance its production ( Fig. 5d ). Although IL-10 production has been shown 33, 38, 39 to render T H 17 cells less pathogenic in autoimmunity, co-production of IL-10 and IL-17a may be the indicated response for clearing certain infections such as Staphylococcus aureus at mucosal sites 40 . This suggests a model where Tsc22d3 is part of a negative feedback loop for the induction of a T H 17 cell subtype that coproduces IL-17 and IL-10 and limits their pro-inflammatory capacity. Tsc22d3 is induced in other cells in response to the steroid dexamethasone 41 , which represses T H 17 differentiation and Rorc expression 42 . Thus, Tsc22d3 may mediate this effect of steroids.
To characterize the role of Tsc22d3 further, we used ChIP-seq to measure its DNA-binding profile in T H 17 cells and RNA-seq following its knockdown to measure its functional effects. There is a significant overlap between Tsc22d3's functional and physical targets (P , 0.01, for example, Il21, Irf4; Supplementary Information and  Supplementary Table 8 ). For example, Tsc22d3 binds to Il21 and Irf4, which also become upregulated in the Tsc22d3 knockdown. Furthermore, the Tsc22d3 binding sites significantly overlap those of major T H 17 factors, including Batf, Stat3, Irf4 and ROR-ct (.5-fold enrichment; Fig. 5d , Supplementary Table 8 and Supplementary  Methods) . This suggests a model where Tsc22d3 exerts its T H 17-negative function as a transcriptional repressor that competes with T H 17positive regulators over binding sites, analogous to previous findings in CD4 1 regulation 29, 43 .
Discussion
We combined a high-resolution transcriptional time course, novel methods to reconstruct regulatory networks, and innovative nanotechnology to perturb T cells, to construct and validate a network model for T H 17 differentiation. The model consists of three consecutive, densely intra-connected networks, implicates 71 regulators (46 novel), and suggests substantial rewiring in 3 phases. The 71 regulators significantly overlap with genes genetically associated with inflammatory bowel disease 44 (11 of 71, P , 10 29 ). Building on this model, we systematically ranked 127 putative regulators (82 novel; Supplementary Table 4 ) and tested top ranking ones experimentally.
We found that the T H 17 regulators are organized into two tightly coupled, self-reinforcing but mutually antagonistic modules, the coordinated action of which may explain how the balance between T H 17, T reg and other effector T-cell subsets is maintained, and how progressive directional differentiation of T H 17 cells is achieved. Within the two modules are 12 novel factors (Figs 4 and 5) , which we further characterized, highlighting four of the factors (others are in Supplementary Note and Supplementary Fig. 13) .
A recent study 29 systematically ranked T H 17 regulators based on ChIP-seq data for known key factors and transcriptional profiles in wild-type and knockout cells. Whereas their network centred on known core T H 17 transcription factors, our complementary approach perturbed many genes in a physiologically meaningful setting. Reassuringly, their core T H 17 network significantly overlaps with our computationally inferred model ( Supplementary Fig. 14) .
The wiring of the positive and negative modules (Figs 4 and 5 ) uncovers some of the functional logic of the T H 17 program, but probably involves both direct and indirect interactions. Our functional model provides an excellent starting point for deciphering the underlying physical interactions with DNA binding profiles 30 or proteinprotein interactions (accompanying paper 45 ). The regulators that we identified are compelling new targets for regulating the T H 17/T reg balance and for switching pathogenic T H 17 into non-pathogenic ones.
METHODS SUMMARY
We measured gene expression profiles at 18 time points (0.5 to 72 h) under T H 17 conditions (IL-6, TGF-b1) or control (T H 0) using Affymetrix microarrays HT_MG-430A. We detected differentially expressed genes using a consensus over four inference methods, and clustered the genes using k-means clustering, with an automatically derived k. Temporal regulatory interactions were inferred by looking for significant (P , 5 3 10 25 and fold enrichment .1.5) overlaps between the regulator's putative targets (for example, based on ChIP-seq) and the target gene's cluster (using four clustering schemes). Candidates for perturbation were ordered lexicographically using network-based and expression-based features. Perturbations were done using SiNW for siRNA delivery.
METHODS
Mice. C57BL/6 wild-type, Irf1 2/2 , Fas 2/2 , Irf4 fl/fl and Cd4 Cre mice were obtained from Jackson Laboratory. Stat1 2/2 and 129/Sv control mice were purchased from Taconic. Il12rb1 2/2 mice were provided by P. Kalipada. Il17ra 2/2 mice were provided by J. Kolls. Irf8 fl/fl mice were provided by K. Ozato. Both Irf4 fl/fl and Irf8 fl/fl mice were crossed to Cd4 Cre mice to generate Cd4 Cre 3Irf4 fl/fl and Cd4 Cre 3Irf8 fl/fl mice. All animals were housed and maintained in a conventional pathogen-free facility at the Harvard Institute of Medicine in Boston (IUCAC protocols: 0311-031-14 (V.K.K.) and 0609-058015 (A.R.)). All experiments were performed in accordance to the guidelines outlined by the Harvard Medical Area Standing Committee on Animals at the Harvard Medical School. In addition, spleens from Mina 2/2 mice were provided by M. Bix (IACUC protocol: 453). Pou2af1 2/2 mice were obtained from the laboratory of R. Roeder 46 . Wild-type and Oct1 2/2 fetal livers were obtained at day E12.5 and transplanted into sublethally irradiated Rag1 2/2 mice as previously described 47 . Cell sorting and in vitro T-cell differentiation. CD4 1 T cells were purified from spleen and lymph nodes using anti-CD4 microbeads (Miltenyi Biotech) then stained in PBS with 1% FCS for 20 min at room temperature with anti-CD4-PerCP, anti-CD62l-APC and anti-CD44-PE antibodies (all Biolegend). Naive CD4 1 CD62l high CD44 low T cells were sorted using the BD FACSAria cell sorter. Sorted cells were activated with plate-bound anti-CD3 (2 mg ml 21 ) and anti-CD28 (2 mg ml 21 ) in the presence of cytokines. For T H 17 differentiation: 2 ng ml 21 rhTGF-b1 (Miltenyi Biotec), 25 ng ml 21 rmIl-6 (Miltenyi Biotec), 20 ng ml 21 rmIl-23 (Miltenyi Biotec), and 20 ng ml 21 rmIL-b1 (Miltenyi Biotec). Cells were cultured for 0.5-72 h and collected for RNA, intracellular cytokine staining, and flow cytometry. Flow cytometry and intracellular cytokine staining. Sorted naive T cells were stimulated with phorbol 12-myristate 13-aceate (PMA) (50 ng ml 21 , Sigmaaldrich), ionomycin (1 mg ml 21 , Sigma-aldrich) and a protein transport inhibitor containing monensin (Golgistop) (BD Biosciences) for 4 h before detection by staining with antibodies. Surface markers were stained in PBS with 1% FCS for 20 min at room temperature, then subsequently the cells were fixed in Cytoperm/ Cytofix (BD Biosciences), permeabilized with Perm/Wash Buffer (BD Biosciences) and stained with Biolegend conjugated antibodies, that is, Brilliant violet 650 antimouse IFN-c (XMG1.2) and allophycocyanin-anti-IL-17A (TC11-18H10.1), diluted in Perm/Wash buffer as described 48 (Fig. 5 and Supplementary Fig. 11 ). To measure the time course of ROR-ct protein expression, a phycoerythrinconjugated anti-retinoid-related orphan receptor-c was used (B2D), also from eBioscience ( Supplementary Fig. 4 ). Foxp3 staining for cells from knockout mice was performed with the Foxp3 staining kit by eBioscience (00-5523-00) in accordance with their 'One-step protocol for intracellular (nuclear) proteins'. Data were collected using either a FACS Calibur or LSR II (Both BD Biosciences), then analysed using Flow Jo software (Treestar) 49, 50 . Quantification of cytokine secretion using ELISA. Naive T cells from knockout mice and their wild-type controls were cultured as described above, their supernatants were collected after 72 h, and cytokine concentrations were determined by ELISA (antibodies for IL-17 and IL-10 from BD Bioscience) or by cytometric bead array for the indicated cytokines (BD Bioscience), according to the manufacturers' instructions ( Fig. 5 and Supplementary Fig. 11 ). Microarray data. Naive T cells were isolated from wild-type mice, and treated with IL-6 and TGF-b1. Affymetrix microarrays HT_MG-430A were used to measure the resulting mRNA levels at 18 different time points (0.5-72 h; Fig. 1b ). Cells treated initially with IL-6, TGF-b1 and with addition of IL-23 after 48 h were profiled at four time points (50-72 h). As control, we used time-and culture-matched wild-type naive T cells stimulated under T H 0 conditions. Biological replicates were measured in 8 of the 18 (Supplementary Fig. 1c ). In an additional data set, naive T cells were isolated from wild-type and Il23r 2/2 mice, and treated with IL-6, TGF-b1 and IL-23 and profiled at four different time points (49 h, 54 h, 65 h, 72 h). Expression data were pre-processed using the RMA algorithm followed by quantile normalization 52 . Detecting differentially expressed genes. Differentially expressed genes (comparing to the T H 0 control) were found using four methods: (1) Fold change. Requiring a twofold change (up or down) during at least two time points. (2) Polynomial fit. We used the EDGE software 53, 54 , designed to identify differential expression in time course data, with a threshold of q-value # 0.01. (3) Sigmoidal fit. We used an algorithm similar to EDGE while replacing the polynomials with a sigmoid function, which is often more adequate for modelling time course gene expression data 55 . We used a threshold of q-value # 0.01. (4) ANOVA. Gene expression is modelled by: time (using only time points for which we have more than one replicate) and treatment ('TGF-b1 1 IL-6' or 'T H 0'). The model takes into account each variable independently, as well as their interaction. We report cases in which the P value assigned with the treatment parameter or the interaction parameter passed an FDR threshold of 0.01.
Overall, we saw substantial overlap between the methods (average of 82% between any pair of methods). We define the differential expression score of a gene as the number of tests that detected it. As differentially expressed genes, we report cases with differential expression score .2.
For the Il23r 2/2 time course (compared to the wild-type T cells) we used methods (1)-(3) (above). Here we used a fold change cutoff of 1.5, and report genes detected by at least two tests. Clustering. We considered several ways for grouping the differentially expressed genes, based on their time course expression data: (1) for each time point, we defined two groups ((a) all the genes that are overexpressed, and (b) all the genes that are under-expressed relative to T H 0 cells (see below)); (2) for each time point, we defined two groups ((a) all the genes that are induced, and (b) all the genes that are repressed, comparing to the previous time point); (3) k-means clustering using only the T H 17 polarizing conditions. We used the minimal k, such that the within-cluster similarity (average Pearson correlation with the cluster's centroid) was higher than 0.75 for all clusters; and, (4) k-means clustering using a concatenation of the T H 0 and T H 17 profiles.
For methods (1) and (2), to decide whether to include a gene, we considered its original mRNA expression profiles (T H 0, T H 17) and their approximations as sigmoidal functions 55 (thus filtering transient fluctuations). We require that the fold change levels (compared to T H 0 (method 1) or to the previous time point (method 2)) pass a cutoff defined as the minimum of the following three values: (1) 1.7; (2) mean 1 s.d. of the histogram of fold changes across all time points; or (3) the maximum fold change across all time points. The clusters presented in Fig. 1b were obtained with method (4). The groupings from methods (1), (2) and (4) are provided in Supplementary Table 2 . Regulatory network inference. We identified potential regulators of T H 17 differentiation by computing overlaps between their putative targets and sets of differentially expressed genes grouped according to methods (1)-(4) above. We assembled regulator-target associations from several sources: (1) in vivo DNA binding profiles (typically measured in other cells) of 298 transcriptional regulators 12-17 ; (2) transcriptional responses to the knockout of 11 regulatory proteins 6, 43, 49, [56] [57] [58] [59] [60] ; (3) additional potential interactions obtained by applying the Ontogenet algorithm (V. Jojic et al., submitted; regulatory model available at: http://www.immgen.org/ModsRegs/modules.html) to data from the mouse ImmGen consortium (http://www.immgen.org; January 2010 release 19 ), which includes 484 microarray samples from 159 cell subsets from the innate and adaptive immune system of mice; (4) a statistical analysis of cis-regulatory element enrichment in promoter regions 18 ; and (5) the transcription factor enrichment module of the IPA software (http://www.ingenuity.com/). For every transcription factor in our database, we computed the statistical significance of the overlap between its putative targets and each of the groups defined above using a Fisher's exact test. We include cases where P , 5 3 10 25 and the fold enrichment .1.5.
Each edge in the regulatory network was assigned a time stamp based on the expression profiles of its respective regulator and target nodes. For the target node, we considered the time points at which a gene was either differentially expressed or significantly induced or repressed with respect to the previous time point (similarly to grouping methods (1) and (2) above). We defined a regulator node as 'absent' at a given time point if: (i) it was under expressed compared to T H 0; or (ii) the expression is low (,20% of the maximum value in time) and the gene was not overexpressed compared to T H 0; or, (iii) up to this point in time the gene was not expressed above a minimal expression value of 100. As an additional constraint, we estimated protein expression levels using the model from ref. 20 and using a sigmoidal fit 55 for a continuous representation of the temporal expression profiles, and the ProtParam software 61 for estimating protein halflives. We require that, in a given time point, the predicted protein level be no less than 1.7-fold below the maximum value attained during the time course, and not be less than 1.7-fold below the T H 0 levels. The timing assigned to edges inferred based on a time-point-specific grouping (grouping methods (1) and (2) above) was limited to that specific time point. For instance, if an edge was inferred based on enrichment in the set of genes induced at 1 h (grouping method (2)), it will be assigned a '1 h' time stamp. This same edge could then only have additional time stamps if it was revealed by additional tests. Selection of nanostring signature genes. The selection of the 275-gene signature ( Supplementary Tables 5 and 6 ) combined several criteria to reflect as many aspects of the differentiation program as was possible. We defined the following requirements: (1) the signature must include all of the transcription factors that belong to a T H 17 microarray signature (comparing to other CD4 1 T cells 51 , see ARTICLE RESEARCH
